Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
120M
-
Shares change
-
-285K
-
Total reported value, excl. options
-
$729M
-
Value change
-
-$6.85M
-
Put/Call ratio
-
1.44
-
Number of buys
-
81
-
Number of sells
-
-65
-
Price
-
$6.05
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q2 2019
182 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q2 2019.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 120M shares
of 303M outstanding shares and own 39.78% of the company stock.
Largest 10 shareholders include BlackRock Inc. (11.7M shares), Magnetar Financial LLC (7.94M shares), VANGUARD GROUP INC (7.67M shares), CNH PARTNERS LLC (6.92M shares), ALPINE ASSOCIATES MANAGEMENT INC. (6.08M shares), GOLDMAN SACHS GROUP INC (5.3M shares), UBS OCONNOR LLC (4.78M shares), ARP AMERICAS LP (4.38M shares), CITADEL ADVISORS LLC (4.35M shares), and WATER ISLAND CAPITAL LLC (3.88M shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.